Legacy MEDSearch

FEBRUARY 28, 2023

Study principal investigator Michel Azizi, Professor of Medicine at Université Paris Cité, Hôpital Européen Georges Pompidou, Paris, France, added, “The pooled analysis of RADIANCE SOLO, TRIO, and RADIANCE II shows a remarkable consistency of effect in patients with mild to moderate hypertension and those with resistant hypertension.

Networking 98

Networking Medical Physicians Safety 98

PM360

AUGUST 21, 2023

Digital Health Networks announced its lineup of features and audio storytelling for the Cinehealth International Health and Wellness Film and Video Festival. This year’s festival takes place live in Philadelphia at Digital Pharma East on September 12 th , followed by a virtual segment at Digital Health Networks ( www.dhn.tv ).

Networking 40

Networking Doctors Media Management 40

European Pharmaceutical Review

NOVEMBER 21, 2024

In his over 11-year tenure at Pfizer thus far, Dr Boshoff he has delivered 24 approved innovative medicines and biosimilars in over 30 indications, according to Pfizer. “Dr Academy of Medical Sciences. “I Furthermore, Dr Roger Dansey will become Interim Chief Oncology Officer, from 1 January 2025.

Medicine 59

Medicine Medical science Biopharma Medical 59

Clarify Health

NOVEMBER 1, 2019

Designing and maintaining a high-performing provider network is difficult; not because there is a shortage of great providers practicing medicine in caring, cost-effective, and patient-centric ways. This is akin to adding providers to your network without reliable data. Is that worth the price?

Networking 52

Networking Retail Insurance Patients 52

European Pharmaceutical Review

MAY 10, 2023

Dr Florian Bieber, Development Platform Head, Biopharmaceuticals, and Chief Medical Officer of Sandoz stated that investment will help to position the site as part of a “growing network of BioTD centres.” These conditions include rheumatic diseases, Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and hidradenitis suppurativa.

Manufacturing 98

Manufacturing Networking Medicine Biopharma 98

European Pharmaceutical Review

NOVEMBER 2, 2022

The clinic will develop pre-clinical studies into early and late phase clinical trials to identify US Food and Drug Administration (FDA)-approved advanced regenerative medicines. The Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute will lead the project.

Food and Drug Administration 98

Food and Drug Administration Medicine Training Electronics 98

Evolve Your Success

NOVEMBER 14, 2023

One of those is sports medicine. As we celebrate International Men’s Day, Samuel Adeyinka interviews Jordan Rawlins about the world of orthopedics, namely sports medicine. What are the different roles in sports medicine medical sales and what do you need to prepare to ensure success in this space? What are you selling?

Medical sales 52

Medical sales Medicine Sales Medical 52

European Pharmaceutical Review

OCTOBER 5, 2023

Maja Pedersen has been appointed as Chief Quality Officer (CQO), to lead FUJIFILM Diosynth Biotechnologies’ global quality team. She explained: “I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture.” “We

Recruitment 105

Recruitment Manufacturing Biopharma Leads 105

Pharmaceutical Technology

MARCH 10, 2023

Sandoz, a division of Novartis , has signed a Memorandum of Understanding (MoU) for constructing a new biologics production plant in Lendava, Slovenia, to support the growing demand for biosimilar medicines worldwide. At Sandoz, we are determined to continue leading the way in driving access to these critical medicines.

Food and Drug Administration 52

Food and Drug Administration Networking Medicine Food 52

European Pharmaceutical Review

APRIL 4, 2024

The scheme aims to support UK advanced therapy medicinal product (ATMP) clinical trials. Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. What key solutions will the investment in the Advanced Therapy Treatment Centre Network provide?

Networking 98

Networking Training Recruitment Healthcare 98

European Pharmaceutical Review

APRIL 28, 2023

The network aims to build a comprehensive contextual understanding of situational data in each National Hub to identify opportunities to address existing gaps and challenges. Each hub has specific and complementary multidisciplinary research expertise.

Networking 98

Networking Medicine Leads Pharmaceutical 98

European Pharmaceutical Review

DECEMBER 23, 2022

With over 90,000 employees across the globe, Sanofi supplies over 5 billion doses of medicines and vaccines every year, supporting the health needs of millions of patients in more than 170 countries. This will not only transform the practice of medicine, but will transform ourselves as an organisation. Standardise manufacturing .

Manufacturing 98

Manufacturing Networking Medicine Electronics 98

Pharmaceutical Technology

JUNE 30, 2022

These cuts due to Covid-19-related deficits can potentially harm research funding, says Poppy Lamberton, PhD, Reader at the Institute of Biodiversity, Animal Health & Comparative Medicine at the University of Glasgow. However, some big pharma players have a history of donating some treatments to the cause, he explains.

Leads 64

Leads Pharma Medicine FDA 64

European Pharmaceutical Review

FEBRUARY 7, 2024

The Rockville facility will join AstraZeneca’s global manufacturing and supply network of nearly 30 manufacturing and supply sites in 16 countries. This facilitates the delivery of more than nine billion doses of medicines annually.

Manufacturing 103

Manufacturing Medicine Networking Patients 103

PM360

AUGUST 12, 2024

CineHealth brings discussion about content and storytelling from key industry thought leaders to leading healthcare conference. The panel will be hosted by Digital Health Networks CEO, Jon Cody and will include: Nathalie Casthely: 2023 CINEHEALTH Finalist, Senior Director, Communications, Cancer Support Community Dr. Don S.

Pharma 59

Pharma Media Networking Education 59

European Pharmaceutical Review

DECEMBER 14, 2023

Decisions to remove medicines from market are not taken lightly and are often based upon all evidence available to inform a benefit/risk balance. Article (Samantha Lane): How can evidence-based medicine (EBM) methodology support drug withdrawals? A rich resource These health records can be a rich text for researchers.

Medicine 116

Medicine Safety Competition Networking 116

Scott’s Directories

AUGUST 13, 2024

Key features of the directory include: Categorization by Specialty: Patients can easily find doctors who specialize in specific areas of medicine, ensuring they receive expert care. By utilizing this directory, patients can make informed decisions about their healthcare, leading to better outcomes.

Doctors 52

Doctors Patients Healthcare Provider Physicians 52

Pharma Marketing Network

DECEMBER 6, 2023

Pioneer healthcare’s transformation.   Healthcare reforms are finally paving the way to affordable access to medicines, yet this progress threatens the development of future life-saving therapies. The Register Now The post Pharma USA 2024 | March 26–27, 2024 appeared first on Pharma Marketing Network. Accelerate patient value.

Pharma 52

Pharma Networking Marketing Medicine 52

European Pharmaceutical Review

FEBRUARY 28, 2024

Cell and gene therapies require a new approach to evidence-gathering ATMPs differ from traditional medicines in several ways and so their analysis methods must also differ. Collaboration leads to progress The prospect of ATMPs offering potentially curative treatments for rare diseases is truly revolutionary. cited2023Oct].

Patients 97

Patients Ethics Healthcare Healthcare 97

Pharma Marketing Network

JUNE 23, 2021

He has worked within life sciences organizations, leading publishers, consultancies, agencies, digital health, and technology solutions support our journeys through illness and to wellness. He often speaks and writes about his passion, EaaM – Experience as a Medicine.

Consulting 52

Consulting Media Networking Leads 52

pharmaphorum

JANUARY 24, 2023

Given the funding environment for innovative medicines that is faced by all pharma, large or small, once assets are approved, however, this 2023 reset seems a necessary response. Medicines manufacturing is energy intensive. Medicines distribution and supply is also an energy intensive and regulated business.

Medicine 93

Medicine Healthcare Healthcare Pharma 93

PM360

OCTOBER 18, 2024

Mathai: There is no better time to join the biopharmaceutical industry than now, whether the company is small or large, intending to make medicines or in healthcare services or diagnostic companies. While using that platform in large companies to create medicines, you are not building a company per se. And so that feels different.

Medicine 52

Medicine Education Prospecting Networking 52

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What types of medicinal products are in short supply and why?

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

pharmaphorum

JULY 20, 2022

DSV’s involvement will provide pre-seed capital for the new ventures, which will be incubated within Cancer Research Horizon’s wet labs with support from scientists among its researcher network. The post Cancer Research UK partnership aims to back 10 new startups appeared first on.

Networking 84

Networking Medicine Patients Leads 84

Pharmaceutical Technology

APRIL 21, 2023

Moderna will join the IBM Quantum Network and the IBM Quantum Accelerator programme. Moderna CEO Stéphane Bancel said: “Since our inception, we have always strived to be at the forefront of cutting-edge technology, leveraging innovations to deliver the greatest possible impact to people through mRNA medicines.

Medicine 98

Medicine Networking Safety Leads 98

Pharmaceutical Technology

APRIL 19, 2023

Everest Medicines has signed a memorandum of understanding with Shanghai Pharma subsidiary SPH Keyuan Xinhua Pharmaceutical (SPH Kyuan) to support the import and channel distribution of XERAVA (eravacycline) in China. Everest Medicines CEO Rogers Yongqing Luo stated: “We are very excited to reach a partnership with SPH Kyuan.

Distribution 52

Distribution Medicine Networking Pharma 52

pharmaphorum

NOVEMBER 1, 2022

Investigating the next generation of genetic medicine through RNA based therapies. RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. Heads of Translational Medicine. Website: [link].

Medicine 52

Medicine Pharmacology Networking Pharma 52

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar.

Medical 103

Medical Networking Healthcare Healthcare 103

pharmaphorum

DECEMBER 16, 2022

CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. million – making it the most expensive medicine in the world – which was above the $2.9 CSL launched the therapy in the US with a list price of $3.5

Medicine 118

Medicine Prospecting Networking Marketing 118

pharmaphorum

SEPTEMBER 16, 2022

George Medicines has partnered with Medisante to provide technology for a study of an experimental triple therapy for hypertension that will allow most subjects to provide data from their own homes. Image source: George Medicines. By 2030, it is projected that over 215 million Africans will have hypertension.

Side effects 52

Side effects Medicine Healthcare Provider Patients 52

European Pharmaceutical Review

NOVEMBER 29, 2022

National Institute for Health and Care Research (NIHR)’s Clinical Research Network. It will also involve experts in infectious diseases and virology who will monitor the flu virus to see if it becomes resistant to the anti-viral drugs tested in the trial.

Medicine 115

Medicine Recruitment Consulting Healthcare 115

Impetus Digital

AUGUST 2, 2024

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

Pharma Marketing Network

OCTOBER 24, 2024

The Rise of Personalized Medicine Pharma marketing isn’t just about mass-market medications anymore; it’s about tailoring treatments. Personalized medicine, often driven by genomic data, is revolutionizing how treatments are marketed. Personalized medicine is like custom-made clothing: it’s tailored for a perfect fit.

Marketing 52

Marketing Pharma Healthcare Healthcare 52

European Pharmaceutical Review

APRIL 2, 2024

She is the Global Lead for the rFC implementation project and is an active contributor to the Analytical Technology Centers within Roche’s Global QC network. She serves as the global lead for the expert network team specialising in endotoxins and pyrogen testing.

Manufacturing 98

Manufacturing Ethics Marketing Networking 98

Pharma Marketing Network

MAY 3, 2023

However, the effects of these advertisements are not always positive, as they can also lead to overdiagnosis, overtreatment, and higher healthcare costs. Healthcare providers may be influenced by the advertisements they see, leading them to prescribe specific medications more frequently than others. References: 1. Goozner, M.

Pharmaceutical 52

Pharmaceutical Healthcare Provider Prescription Healthcare 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. UR Medicine, Rochester, New York. In a fiercely competitive U.S. IDN status: Intermediate.

Networking 52

Networking Healthcare Healthcare Competition 52

European Pharmaceutical Review

JULY 25, 2022

As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 104

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 104